Pakistan Company News – Medical/Health Care

Category Archives: Medical/Health Care

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung cancer Phase I Study 10 data shows clinical activity with combination treatment in 2nd-line metastatic urothelial carcinom...

گڈسینڈ کا وٹامن کے2 نیو یارک کے ٹائمز اسکوائر اور پیرس ففٹین ڈسٹرکٹ پہنچ گیا، چینی فہم کی مضبوطی دنیا بھر میں لے جاتا ہوا

شینچن، چین، 28 فروری 2018ء/پی آرنیوزوائر/– 2018ء کے آغاز پر گڈسینڈ فارما …

Goodscend’s Vitamin K2 Landed in New York Times Square and Paris Fifteen District, Delivering the Strength of China Intelligence to The World

SHENZHEN, China, Feb. 28, 2018 /PRNewswire/ — At the beginning of 2018, Goodscend Pharm. Sci & Tech. Co., Ltd. (“Goodscend”) promoted its vitamin brand K2 on the large billboards overlooking New York’s Times Square and in the 15th arrondissement of Paris. Vitamin K2 is recognized by the global healthcare community as a revolutionary …

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU INDIANAPOLIS, Feb. 13, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for Olumiant® (baricitinib) 4 mg and 2 mg film-coated …

Sprint Acquires 33 Percent of TIDAL and Creates Game-Changing Partnership

TIDAL and its artists to deliver exclusive content to help Sprint acquire new customers, reward current customers Sprint will make TIDAL available to its 45 million post and prepaid customers Sprint CEO Marcelo Claure to join TIDAL Board of Directors NEW YORK and OVERLAND PARK, Kansas, Jan. 23, 2017 /PRNewswire/ — Global music and entertainment …

Merck Opens Production Facility Exclusively for Meglumine in Spain

– Regulatory compliant, FDA-audited facility based in Mollet des Vallès, Spain – The only facility in Europe solely dedicated to meglumine production DARMSTADT, Germany, Jan. 17, 2017 /PRNewswire/ — Merck, a leading science and technology company, today announced the opening of a facility in Mollet des Vallès, Spain …